OTC/DTC Infectious Disease Diagnostics Market Report 2023: New Sampling Technology and Rapid and Multiplex Tests Present Opportunities
January 04, 2023 07:03 ET
|
Research and Markets
Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends, COVID-19 Adjusted Forecasts: by Application, by Channel, by Country. With Market...
Assembly Biosciences Announces Promising Interim Results from Two Clinical Trials Evaluating Highly Potent Next-Generation Core Inhibitor Candidates ABI-H3733 and ABI-4334
December 19, 2022 08:00 ET
|
Assembly Biosciences, Inc.
In initial ABI-H3733 cohort of 50 mg in 28-day Phase 1b study, six of eight HBV patients on treatment reached lower limit of quantification for HBV DNA by day 21 and patients showed a mean reduction...
Provectus Biopharmaceuticals Announces Decision to Not Undertake Reverse Split of Outstanding and Authorized Equities in 2022; Expects to Seek Same Stockholder Approval Again in 2023
December 12, 2022 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company’s Board of Directors (Board) has decided to not undertake the reverse stock split and...
Assembly Biosciences Reports Third Quarter 2022 Financial Results and Recent Highlights and Announces Upcoming Conference Participation
November 08, 2022 16:05 ET
|
Assembly Biosciences, Inc.
Phase 1a Trial of Next-Generation Core Inhibitor, ABI-4334, Now Underway Following Clinical Trial Application (CTA) Clearance SOUTH SAN FRANCISCO, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Assembly...
Virology Specimen Collection Global Market to Reach $6.76 Billion by 2026 at a CAGR of 4%
November 04, 2022 09:18 ET
|
Research and Markets
Dublin, Nov. 04, 2022 (GLOBE NEWSWIRE) -- The "Virology Specimen Collection Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global virology specimen...
Virology Market Growing Demands, 2022 | Latest Innovations, Industry Size-Share, Key Development Trends, Market Performance, Product Situation, Growth Opportunities, Competitive Situation, and Future Market Outlook Till 2028
September 01, 2022 08:38 ET
|
Industry Research
Pune, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Global “Virology Market” 2022-2028 report discovers comprehensive insights on key manufacturers with share information, market size and projection, key...
Insights on the Bioanalytical Testing Services Global Market to 2027 - Emerging Countries in the Asia Pacific Region Present Opportunities
August 12, 2022 04:28 ET
|
Research and Markets
Dublin, Aug. 12, 2022 (GLOBE NEWSWIRE) -- The "Global Bioanalytical Testing Services Market (2022-2027) by Type, Application, End-User, Geography, Competitive Analysis and the Impact of Covid-19...
Provectus Biopharmaceuticals Announces Stockholder Approval to Undertake Reverse Split of Outstanding Equities and Reduce Number of Authorized Equities by Same Ratio
June 23, 2022 09:41 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, June 23, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company’s shareholders have approved the proposals of Provectus’ Board of Directors (Board) to seek...
Global OTC/DTC Infectious Disease Diagnostics Market Report 2022-2026: Sleeping Giant of Over the Counter and Direct to Consumer Diagnostics is Set to Create a Broad New Diagnostic Industry
June 17, 2022 04:13 ET
|
Research and Markets
Dublin, June 17, 2022 (GLOBE NEWSWIRE) -- The "OTC/DTC Infectious Disease Diagnostics Strategies and Trends for Over the Counter and Direct To Consumer. Forecasts by Application by Channel by...
Provectus Biopharmaceuticals Seeks Stockholder Approval at 2022 Annual Meeting for Authority to Undertake Reverse Split of Outstanding Equities and Reduce Number of Authorized Equities by Same Ratio
April 19, 2022 16:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, April 19, 2022 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that, in conjunction with the filing of the Company’s preliminary 2022 proxy statement (Pre-14A), Provectus’...